Active	Status	Sponsor type	Region	Phase	Filter
2 Active 8 Inactive 10 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Zecuity (transdermal sumatriptan) / Teva
BOSS-002, NCT05785390: Study of the Safety, Tolerability and Efficacy of NP-101 in Treating High Risk Participants Who Are Covid-19 Positive.	Recruiting	2	308	US	NP-101, TQ Formula, Placebo	Novatek Pharmaceuticals	COVID-19	10/24	10/24
NCT06217094: Study of NP-101 in Patients With Unresectable Hepatocellular Carcinoma (HCC) Undergoing Y-90 Treatment	Not yet recruiting	1	18	NA	NP-101 (3 g), NP-101 (4.8 g), NP-101 (6 g)	University of Florida, Novatek	Hepatocellular Carcinoma	07/26	09/29